Current modeling approaches to experimental cognitive impairment (a literature review)

The aim of the work is to review the professional literature sources from the scientific database PubMed mainly for the last 20 years analyzing the modern view on approaches to experimental modeling of cognitive impairment. Materials and methods. A review of the scientific literature over the past 2...

Full description

Saved in:
Bibliographic Details
Main Authors: D. V. Tymofiiv (Author), O. V. Hancheva (Author)
Format: Book
Published: Zaporozhye State Medical University, 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_af86d5a814b94881b01b42d6588a4aaa
042 |a dc 
100 1 0 |a D. V. Tymofiiv  |e author 
700 1 0 |a O. V. Hancheva  |e author 
245 0 0 |a Current modeling approaches to experimental cognitive impairment (a literature review) 
260 |b Zaporozhye State Medical University,   |c 2022-08-01T00:00:00Z. 
500 |a 10.14739/2409-2932.2022.2.259429 
500 |a 2306-8094 
500 |a 2409-2932 
520 |a The aim of the work is to review the professional literature sources from the scientific database PubMed mainly for the last 20 years analyzing the modern view on approaches to experimental modeling of cognitive impairment. Materials and methods. A review of the scientific literature over the past 20 years was performed. The lack of requisite knowledge about the pathogenesis of cognitive impairment and the wide range of risk factors for these conditions continue to be major challenges in the development of guidelines on early diagnosis and treatment. The literary analysis suggests that all modeling approaches to experimental cognitive impairment are currently divided into two groups: cell culture and animal models. Conclusions. Experimental modeling of cognitive impairment remains important in addition to clinical and population-based studies. In recent years, the problem of selecting an adequate model to study cognitive impairment, which is a central clinical manifestation of various neurological diseases (Alzheimer's and Parkinson's diseases, traumatic brain injury, vascular, demyelinating, and infectious diseases, metabolic aberrations and hormonal imbalance, neurodegenerative diseases of the central nervous system) is becoming increasingly relevant. The choice of model and experimental material - animals or cultures (invertebrate and mammalian cells) is based on a clear understanding of the study design and depends on the ultimate goal of research. 
546 |a EN 
546 |a RU 
546 |a UK 
690 |a cognition disorders 
690 |a experimental model 
690 |a cell cultures 
690 |a animal models 
690 |a rats 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, Vol 15, Iss 2, Pp 208-214 (2022) 
787 0 |n http://pharmed.zsmu.edu.ua/article/view/259429/258794 
787 0 |n https://doaj.org/toc/2306-8094 
787 0 |n https://doaj.org/toc/2409-2932 
856 4 1 |u https://doaj.org/article/af86d5a814b94881b01b42d6588a4aaa  |z Connect to this object online.